Manulife combines strong Asia growth, improving wealth-management earnings, and solid capital with a valuation that still looks reasonable. The report supports a Buy view as execution improves across its highest-growth businesses.
Manulife Financial Corp. (MFC) offers a balanced medium-term investment case built on Asia growth, expanding wealth-management earnings, strong capital, and a forward earnings profile that is stronger than its trailing results. Q2 2026 core EPS rose 16% year over year to $1.09, core earnings increased 12% to $1.923B, and new business CSM grew 16% to $1.024B. These figures show operating momentum rather than a purely market-driven earnings lift.
The main reason for a Buy stance is the combination of a 13.7x forward P/E, a 0.8x PEG ratio, 22.4% year-over-year earnings growth in the financial data, and analyst EPS estimates rising from $4.53 in 2026 to $5.51 in 2028. Asia generated 47% of 2025 core earnings contribution, while Global Wealth and Asset Management contributed 25% of operating core earnings. That mix gives MFC a clearer growth engine than its traditional life-insurance label implies.
The case is not risk-free. Canada core earnings fell 10% year over year in Q2 2026 because of group-insurance claims and expenses, Global WAM recorded outflows in retirement and retail channels despite $0.4B of quarterly net inflows, and the analyst target of $34.28 is below the report's $40.00 fair-value estimate. The balance sheet and operating data support accumulation for moderate-risk investors, but the stock does not merit an aggressive growth multiple without continued execution in Asia and wealth management.
Founded in 1887 and headquartered in Toronto, Manulife operates across Canada, the United States, Asia, and international markets. The company employs about 37,000 people and operates through insurance, annuity, wealth-management, asset-management, banking-adjacent, and reinsurance businesses. In the United States, the main brand is John Hancock.
Manulife's business model combines long-duration insurance liabilities with fee-based and spread-based wealth activities. The company reported 2025 assets under management and administration of approximately $1.1T in Global WAM, while the investor presentation showed total company AUMA of $3.8T in 2025. This scale gives MFC multiple ways to monetize customer relationships through insurance, retirement, investment, and advisory products.
Distribution is a central asset. Manulife has more than 109,000 agents and more than 36 million customers, according to its business disclosures. The company sells through affiliated agents, independent advisors, banks, brokers, pension consultants, institutional channels, and direct marketing. That network is difficult to reproduce quickly, particularly in Asian markets where agency productivity remains a major competitive variable.
Asia is the strongest segment in the current growth profile. Q2 2026 Asia APE sales increased 21% year over year, with double-digit growth in Hong Kong, Singapore, and Japan. Hong Kong APE sales rose 37%, driven by savings products across distribution channels. Asia core earnings increased 21% year over year to a record level, according to management.
Global WAM is the second major growth pillar. The segment produced $0.4B of net inflows in Q2 2026, supported by institutional business, CQS, and Comvest. Core earnings rose 9% year over year, and the core EBITDA margin expanded 110 basis points to 31.2%. The result was tempered by outflows in North American retirement and Canadian active mutual funds, but record gross flows and the return to positive aggregate net flows are constructive operating markers.
Canada and the United States provide scale and diversification, although their near-term results are less even. Canada APE sales rose 23% in Q2 2026, led by group insurance and participating life, while core earnings declined 10% because of group-benefit claims and expenses. U.S. APE sales grew 12%, and U.S. core earnings rebounded as life and long-term-care claims experience improved.
Corporate and other activities include property and casualty reinsurance, run-off reinsurance, timberland, agricultural portfolios, and other investment businesses. The long-term-care reinsurance transaction with Munich Re transferred biometric risk on $3.2B of reserves at an 80% quota share, reducing MFC's overall LTC morbidity risk by 24% after prior transactions.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Participating life and savings products are the clearest flagship franchise in the current operating data. Hong Kong APE sales increased 37% in Q2 2026, with savings products contributing across all channels. Manulife also introduced an insurance savings solution that combines participating-life features with investment diversification through a Manulife CQS strategy.
The product proposition works because it combines protection, savings, legacy planning, and investment exposure in one relationship. Management also expanded global high-net-worth offerings with two insurance solutions focused on wealth protection and legacy planning. These products fit customers seeking long-duration financial planning rather than a single transaction.
The product mix still requires discipline. Management said Asia new business value growth was partly offset by business-mix changes, while U.S. value metrics were affected by product mix despite 12% APE sales growth. The evidence supports strong product demand, but volume alone does not guarantee equal profitability across policies.
Manulife is using artificial intelligence in underwriting, claims, advisor productivity, document processing, and customer service. The company was recognized by Evident as the number-one life insurer for AI maturity for the second consecutive year and ranked first in North America among the insurers covered in that assessment. Celent also named Manulife a Model Insurer for Data, Analytics and AI.
The enterprise AI platform is designed to let developers reuse capabilities across markets and businesses. Global WAM has launched agentic AI solutions, including document-intelligence readers and knowledge assistants. The financial payoff is visible first through process efficiency and advisor capacity, while the longer-term payoff depends on whether these tools improve underwriting quality, retention, and operating margins.
Distribution scale strengthens the technology advantage. In Asia, Million Dollar Round Table membership rose 9% year over year, while APE sales per active agent increased more than 30%. AI-enabled training and advisor capability programs therefore have a measurable commercial channel, rather than existing only as a corporate technology project.
Manulife's operating chain runs from customer acquisition and underwriting to policy administration, claims management, asset-liability management, and investment distribution. The company uses agents, banks, brokers, independent advisors, pension consultants, and institutional relationships to originate business. That multi-channel structure helped Q2 insurance sales grow across all major segments.
Long-term-care operations provide a direct example of process improvement. Manulife's customer-care and claims-management program has generated run-rate LTC claim savings of more than 6%, including reductions in fraud, waste, and abuse. The company also uses premium repricing to reduce claims variability and expects the remaining LTC block to begin declining over the next 5 to 10 years.
Asset management remains integrated with insurance operations. In the Munich Re LTC transaction, MFC transferred biometric risk while retaining the asset portfolio and its management economics. Management stated that the assets remain within the broader asset-liability-management framework, with no current plan to change the investment strategy. This structure preserves earnings potential and capital generation tied to the retained assets.
The life and health insurance market gives Manulife a large addressable opportunity. Mordor Intelligence estimates global health insurance premiums at $1.98T in 2025, rising to $3.11T by 2031 at a 7.8% CAGR. Swiss Re forecasts global life premium growth of 2.7% annually in 2025 and 2026, supported by aging populations, healthcare costs, and product bundling.
Asia is the most important market for MFC's growth strategy. Management is targeting Asia at 50% of core earnings contribution by 2027, compared with 47% in 2025. The Q2 2026 results support that target through 21% Asia APE sales growth, 21% Asia core-earnings growth, and broad-based strength in Hong Kong, Singapore, and Japan.
Wealth management expands the market beyond insurance premiums. Global WAM serves retirement, retail, and institutional customers, with 2025 core-earnings mix of 57% retirement, 31% retail, and 12% institutional. The segment's $0.4B of Q2 2026 net inflows and 31.2% core EBITDA margin show why fee-based activities matter to the company's medium-term earnings mix.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Manulife serves several distinct customer groups. Individual customers buy life, health, annuity, savings, and wealth-protection products. Employers and their employees use group benefits and retirement plans. High-net-worth customers use legacy-planning and participating-life solutions. Institutional clients use asset-management and retirement solutions through Global WAM.
The geographic customer mix is particularly valuable. Asia contributed 38% of 2025 core-earnings mix in the investor presentation and 47% of total core-earnings contribution in the 2025 business summary, reflecting different presentation bases. Hong Kong, Japan, Singapore, Vietnam, Mainland China, and emerging Asian markets give MFC exposure to a broad set of household savings and protection needs.
Customer behavior is mixed in wealth management. Institutional demand helped produce Q2 net inflows, while retirement outflows reflected plan-sponsor redemptions and member withdrawals after market appreciation. Retail outflows were tied primarily to active mutual-fund redemptions through Canadian third-party intermediaries. The diversification of channels reduces reliance on one customer type, but it does not eliminate flow sensitivity.
MFC competes with Sun Life Financial (SLF) and Great-West Lifeco (GWO) in Canadian life, health, wealth, and group benefits. In Asia, AIA Group and Prudential plc are major competitors. In the United States, Prudential Financial (PRU), banks, asset managers, digital firms, and insurtech companies compete for retirement, life, wealth, and advisory relationships.
Scale is a meaningful differentiator. Manulife's Global WAM reported approximately $1.1T of assets under management and administration in 2025, while Prudential Financial reported approximately $1.609T of AUM at December 31, 2025. The comparison places MFC among substantial global platforms, although the businesses are not identical in product mix or reporting scope.
MFC's strongest competitive advantages are geographic diversification, Asian distribution, product breadth, and its combination of insurance and wealth management. The Q2 2026 increase in Asia agent productivity and the 31.2% Global WAM core EBITDA margin support that position. Competitive pressure remains visible in Canadian mutual-fund redemptions and in the need to maintain advisor relationships as digital distribution expands.
Interest rates and equity markets affect both insurance economics and wealth-management flows. OECD research linked 2024 life-premium growth to high interest rates and strong equity markets, while MFC reported higher-than-expected public-equity returns in Q2 2026 that helped net income exceed core earnings. The same market exposure can work in reverse when asset prices or investment spreads weaken.
The most specific geopolitical issue is Chinese tax enforcement related to offshore insurance and investment structures. Management said Mainland Chinese visitors represented about 25% of Hong Kong sales, while the domestic Hong Kong franchise represented about 75% of year-to-date sales. Management also said the structural reasons for accessing Hong Kong include currency diversification, investment access, and services, not tax benefits alone.
The Q2 discussion supports a manageable risk assessment rather than a full withdrawal from the Hong Kong thesis. Management expects the Mainland Chinese customer trend to continue and said any short-term effects would be manageable, while acknowledging that enforcement developments require close tracking. Asia's 21% core-earnings growth and Hong Kong's 37% APE sales growth provide the operating evidence behind that confidence.
Aging populations, rising healthcare costs, and the U.S. mortality protection gap also support demand for life and health products. Swiss Re estimated the U.S. mortality protection gap at almost $83B, while Manulife's longevity preparedness tool and health-and-wellness offerings show how the company is positioning products around longer lifespans.
A- balance sheet strength is supported by solid capital and a business mix that includes fee-based wealth management alongside long-duration insurance liabilities.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q2 2026 core EPS rose 16% year over year to $1.09 and core earnings climbed 12% to $1.923B, showing broad operating momentum.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Analyst EPS estimates rise from $4.53 in 2026 to $5.51 in 2028, pointing to a stronger forward earnings profile than trailing results suggest.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →A 13.7x forward P/E and 0.8x PEG leave Manulife looking reasonably priced versus its growth outlook, even after a strong run in Asia and wealth management.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report's $40 fair value sits above the $34.28 analyst target, implying the market still underappreciates execution in Asia and Global WAM.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Manulife enters the medium-term period with a stronger growth profile than its mature-market insurance exposure suggests. Q2 2026 delivered 16% core EPS growth, 21% Asia core-earnings growth, 9% Global WAM core-earnings growth, and a 136% LICAT ratio. The company is also reducing long-term-care morbidity risk while retaining asset-management economics.
The investment case depends on execution rather than financial engineering. Asia must continue converting distribution productivity into profitable new business, Global WAM must defend positive flows and its 31.2% margin, and Canada must stabilize group-insurance claims. With those conditions in place, the report's $40.00 fair-value estimate supports a Buy recommendation for moderate-risk investors prepared to hold through normal insurance and market volatility.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Manulife combines a cash-generative insurance base with faster-growth exposure in Asia and Global WAM. FY2025 results, a 10% dividend hike, and a new buyback plan support a disciplined Buy case.
Manulife Financial Corporation (MFC) drops after first-quarter 2026 earnings disappointed on the headline EPS line, even as core earnings and Asia growth remained solid. The selloff came on heavy volume, suggesting investors are resetting expectations rather than abandoning the long-term story.
Intuitive Surgical, Inc. (ISRG) drops after investors reassess its post-earnings growth outlook. Despite strong Q2 results, slower procedure growth, tariff pressure, and a premium valuation are weighing on the stock.